Roderick MacKinnon

Roderick MacKinnon
PotassiumChannel · CC BY-SA 3.0 · source
Name	Roderick MacKinnon
Birth date	1956
Birth place	Boston, Massachusetts
Nationality	American
Fields	Biochemistry, Structural Biology, Neuroscience
Workplaces	Rockefeller University, Harvard University, Massachusetts Institute of Technology
Alma mater	Brandeis University, Tufts University School of Medicine
Known for	Structure of voltage-gated and potassium channels
Awards	Nobel Prize in Chemistry, Louisa Gross Horwitz Prize, Wiley Prize

Contents

Roderick MacKinnon is an American biophysicist and structural biologist noted for determining the three-dimensional structure of potassium channels, elucidating the molecular basis of ion selectivity and conduction. His work at institutions including Rockefeller University, Harvard University, and collaborations with laboratories associated with Massachusetts Institute of Technology and Brandeis University transformed understanding in biochemistry, neuroscience, and physiology. MacKinnon's findings have influenced research in pharmacology, cardiology, and molecular biology and earned him major scientific honors.

Early life and education

MacKinnon was born in Boston, Massachusetts and raised in a family with exposure to science and medicine through local hospitals and universities. He completed undergraduate studies at Brandeis University where he studied chemistry under faculty tied to research networks including Harvard University and Massachusetts Institute of Technology. He attended Tufts University School of Medicine for medical training before shifting toward research, joining laboratories associated with figures from Columbia University, Stanford University, and University of Chicago during his early postgraduate development. His formative mentors and colleagues included investigators with appointments at Rockefeller University, Yale University, and University of California, Berkeley.

MacKinnon established his laboratory at Rockefeller University where he pursued structural studies integrating techniques from groups at Bell Labs, Max Planck Institute, and European Molecular Biology Laboratory. He leveraged crystallography approaches developed at Brookhaven National Laboratory and adapted methods propagated from work at Argonne National Laboratory and Stanford Synchrotron Radiation Lightsource. His laboratory collaborated with structural biology teams at Columbia University Irving Medical Center and instrumentation specialists at SLAC National Accelerator Laboratory. Over the years he maintained connections with researchers at Cold Spring Harbor Laboratory, University of Oxford, and University College London.

MacKinnon's research solved the high-resolution structure of a bacterial potassium channel using X-ray crystallography, building on electrophysiology paradigms established by scientists at University of Chicago, University of Cambridge, and Johns Hopkins University. His structural models revealed the selectivity filter mechanism that discriminates potassium from sodium, integrating concepts from work at California Institute of Technology, Princeton University, and University of California, San Francisco. The studies bridged techniques from laboratories at Yale University School of Medicine, Scripps Research, and The Rockefeller University Hospital, and influenced investigations into channel gating by groups at Max Delbrück Center, University of Pennsylvania, and Massachusetts General Hospital. Follow-up work examined toxin interactions with channels, informed by researchers at University of Sydney, Hebrew University of Jerusalem, and University of Tokyo, and stimulated drug discovery efforts in collaboration with scientists at Pfizer, Novartis, and GlaxoSmithKline. The findings became foundational for fields connected to cardiac electrophysiology research at Cleveland Clinic and Mayo Clinic, and for computational modeling initiatives at National Institutes of Health and Lawrence Berkeley National Laboratory.

MacKinnon's achievements were recognized with major prizes including the Nobel Prize in Chemistry and the Louisa Gross Horwitz Prize. He also received awards such as the Wiley Prize in Biomedical Sciences, honors from the American Academy of Arts and Sciences, and membership in the National Academy of Sciences. Other recognitions connected him to societies like the Biophysical Society, the Royal Society, and honorary degrees from institutions including Columbia University and Harvard University. He has delivered named lectures at venues such as Cold Spring Harbor Laboratory and universities like Yale University and Princeton University.

MacKinnon has collaborated widely with investigators from institutions including Stanford University School of Medicine, Imperial College London, and ETH Zurich, shaping generations of scientists who continued work at places like MIT, UCSF, and Johns Hopkins University School of Medicine. His legacy includes influencing pharmaceutical research at companies like Merck and Bristol-Myers Squibb and inspiring educational programs at Brandeis University and Tufts University. He is frequently cited in literature connected to awards from organizations such as The Rockefeller Foundation and the Guggenheim Foundation, and his laboratory's publications are standard references in curricula at University of Cambridge and University of Oxford. His broader impact is evident in translational projects at Children's Hospital Boston and policy discussions at the National Academy of Medicine.